May 15, 2026

Why FDA Said No to a Melanoma Drug

Questions over trial design and political pressure shadowed the rejection of Replimune’s RP1 treatment.

KFF Health News

May 14, 2026

Guselkumab Shows Psoriasis Benefit in Darker Skin Tones

Randomized trial suggests sustained clearance across darker skin tones.

Conexiant

May 14, 2026

Low-Dose Oral Minoxidil Monitoring Questioned

A retrospective hair clinic study found stable blood pressure, heart rate, weight, and laboratory measures during follow-up of up to 30 months.

Conexiant

May 13, 2026

AI Discharge Summaries Show Low Harm Risk

Most reviewed summaries were rated as posing no harm risk, although omissions remained common.

Conexiant

May 13, 2026

AOPT Plus Collagen May Ease Rosacea

Randomized trial suggests better short-term outcomes and lower recurrence at 24 weeks

Conexiant

May 13, 2026

Medical Oddities: Ancient Practice Calms Modern BP

Ancient workouts, anxious ears, tea gains, limb regrowth, and furry tongues collide.

Conexiant

May 08, 2026

Fabricated Citations Are Reaching Medical Journals

A large audit of biomedical publications suggests fabricated references are increasingly appearing in peer-reviewed papers — often in ways that are difficult for reviewers and readers to detect.

Conexiant

May 08, 2026

Amputation Rates Rose in Opioid-Related Hospitalizations

National inpatient analysis found steeper increases in amputations during opioid-related hospitalizations, particularly in the Northeast and West.

Conexiant

May 07, 2026

Optimizing Nodal Staging for Early Metastasis Detection in cSCC

Ultrasonography, CT may be superior, but have limited benefit in patients who are immunosuppressed. 

Conexiant

May 07, 2026

Tirzepatide's Surprising Skin Side Effect

A single case report described possible lichen planus pigmentosus inversus following tirzepatide initiation.

Conexiant